2026 NPPES data Specialist NPI 1972503183 M.D.
Verify on CMS →

DEBORAH HAMBY, M.D.

Specialist in ROSEVILLE, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
482
Medicare Part D claims · 161 beneficiaries · Specialist avg: 1K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.7801/100
▲ 14 pts above national avg 83.1 · [object Object]
Industry payments
$267.96
14 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DEBORAH HAMBY, M.D. reported a CMS MIPS final score of 96.7801/100 — above the 83.1 national average — and filed 482 Medicare Part D claims in 2023.

96.7801/100
MIPS score · +14 vs avg
482
Part D claims, 2023
93%
generic prescribing
$267.96
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DEBORAH HAMBY, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

97 Top 17% higher than 83% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about DEBORAH HAMBY, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/29/2005

NPI 1972503183

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

482 67% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

96.7801/100 13.68010000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Michigan

How Specialist compares to other specialties among Michigan providers

Michigan providers

Specialist share within Michigan

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Michigan

Medicare quality performance — MIPS

DEBORAH HAMBY, M.D.'s 2023 MIPS final score plotted against the Specialist national average

High performer (top quartile)
MIPS Final Score
96.7801/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 96.7801/100 vs national avg 83.1

0%100%National avg83%96.8%
MIPS final score (Specialist) — 96.7801/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DEBORAH HAMBY, M.D. is a Specialist provider practicing in ROSEVILLE, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1972503183. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DEBORAH HAMBY, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 29751 LITTLE MACK AVE, ROSEVILLE, MI, 48066, with a listed phone of (586) 415-6200. NPI 1972503183 was issued on 07/29/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HAMBY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 482 prescription claims written by this provider, covering 161 Medicare beneficiaries and totaling roughly $36K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.7801/100 for the 2023 performance year (Quality 96.2118), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

29751 LITTLE MACK AVE
ROSEVILLE, MI 48066

Provider Details

NPI 1972503183
Specialty Specialist
Credentials M.D.
Gender Female
NPI Issued 07/29/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.7801
Final Score
Avg: 83.1
96.2118
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where DEBORAH HAMBY, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ASCENSION MEDICAL GROUP MICHIGAN
MACOMB, MI
TOGETHER WOMEN'S HEALTH MEDICAL GROUP, P.C.
MACOMB, MI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DEBORAH HAMBY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$268

Largest payer

Astellas Pharma US Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to DEBORAH HAMBY, M.D.. To verify DEBORAH HAMBY, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

DEBORAH HAMBY, M.D. — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 482 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

482
Total Claims
$36K
Total Drug Cost
161
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
920
Total Day Supply
24,885
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$17K
Generic Drug Cost
$19K
Antibiotic Claims
48

Patient Demographics

Average Patient Age
69.5 years
Avg HCC Risk Score
0.85
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Estradiol
96
Alendronate Sodium
42
Raloxifene Hcl
32
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
28
Valacyclovir
Valacyclovir Hcl
28
Fluconazole
27
Metronidazole
19
Nystatin-Triamcinolone
Nystatin/Triamcinolone Acet
16
Clobetasol Propionate
15
Estradiol-Norethindrone Acetat
Estradiol/Norethindrone Acet
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How DEBORAH HAMBY, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

DEBORAH HAMBY, M.D.'s 482 claims are below the specialty average of 1,474.

Nearby Specialist Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as HAMBY.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is DEBORAH HAMBY, M.D.'s specialty?
DEBORAH HAMBY, M.D. specializes in Specialist and practices in ROSEVILLE, Michigan. Credentials: M.D..
How much does DEBORAH HAMBY, M.D. prescribe under Medicare Part D?
In 2023, DEBORAH HAMBY, M.D. wrote 482 Medicare Part D claims totaling $36K in drug costs for 161 beneficiaries.
What is DEBORAH HAMBY, M.D.'s Medicare quality score?
DEBORAH HAMBY, M.D. has a CMS MIPS Final Score of 96.7801/100 (Quality: 96.2118). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DEBORAH HAMBY, M.D. located?
DEBORAH HAMBY, M.D. is located at 29751 LITTLE MACK AVE, ROSEVILLE, MI, 48066. Phone: (586) 415-6200.
What is DEBORAH HAMBY, M.D.'s NPI number?
DEBORAH HAMBY, M.D.'s National Provider Identifier (NPI) is 1972503183, issued on 07/29/2005.
Does DEBORAH HAMBY, M.D. prescribe more brand-name or generic drugs?
DEBORAH HAMBY, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $17K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does DEBORAH HAMBY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DEBORAH HAMBY, M.D.'s most frequently prescribed drugs include Estradiol, Alendronate Sodium, Raloxifene Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DEBORAH HAMBY, M.D. accept Medicare?
DEBORAH HAMBY, M.D. appears in CMS Medicare data with 482 Part D claims and 161 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DEBORAH HAMBY, M.D.'s credentials?
DEBORAH HAMBY, M.D.'s NPI is 1972503183 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology